Abstract:Full Field Digital Mammograms (FFDMs) and Digital Breast Tomosynthesis (DBT) are the two most widely used imaging modalities for breast cancer screening. Although DBT has increased cancer detection compared to FFDM, its widespread adoption in clinical practice has been slowed by increased interpretation times and a perceived decrease in the conspicuity of specific lesion types. Specifically, the non-inferiority of DBT for microcalcifications remains under debate. Due to concerns about the decrease in visual acuity, combined DBT-FFDM acquisitions remain popular, leading to overall increased exam times and radiation dosage. Enabling DBT to provide diagnostic information present in both FFDM and DBT would reduce reliance on FFDM, resulting in a reduction in both quantities. We propose a machine learning methodology that learns high-level representations leveraging the complementary diagnostic signal from both DBT and FFDM. Experiments on a large-scale data set validate our claims and show that our representations enable more accurate breast lesion detection than any DBT- or FFDM-based model.
Abstract:Magnetic Resonance (MR) imaging, despite its proven diagnostic utility, remains an inaccessible imaging modality for disease surveillance at the population level. A major factor rendering MR inaccessible is lengthy scan times. An MR scanner collects measurements associated with the underlying anatomy in the Fourier space, also known as the k-space. Creating a high-fidelity image requires collecting large quantities of such measurements, increasing the scan time. Traditionally to accelerate an MR scan, image reconstruction from under-sampled k-space data is the method of choice. However, recent works show the feasibility of bypassing image reconstruction and directly learning to detect disease directly from a sparser learned subset of the k-space measurements. In this work, we propose Adaptive Sampling for MR (ASMR), a sampling method that learns an adaptive policy to sequentially select k-space samples to optimize for target disease detection. On 6 out of 8 pathology classification tasks spanning the Knee, Brain, and Prostate MR scans, ASMR reaches within 2% of the performance of a fully sampled classifier while using only 8% of the k-space, as well as outperforming prior state-of-the-art work in k-space sampling such as EMRT, LOUPE, and DPS.
Abstract:The study of Graph Neural Networks has received considerable interest in the past few years. By extending deep learning to graph-structured data, GNNs can solve a diverse set of tasks in fields including social science, chemistry, and medicine. The development of GNN architectures has largely been focused on improving empirical performance on tasks like node or graph classification. However, a line of recent work has instead sought to find GNN architectures that have desirable theoretical properties - by studying their expressive power and designing architectures that maximize this expressiveness. While there is no consensus on the best way to define the expressiveness of a GNN, it can be viewed from several well-motivated perspectives. Perhaps the most natural approach is to study the universal approximation properties of GNNs, much in the way that this has been studied extensively for MLPs. Another direction focuses on the extent to which GNNs can distinguish between different graph structures, relating this to the graph isomorphism test. Besides, a GNN's ability to compute graph properties such as graph moments has been suggested as another form of expressiveness. All of these different definitions are complementary and have yielded different recommendations for GNN architecture choices. In this paper, we would like to give an overview of the notion of "expressive power" of GNNs and provide some valuable insights regarding the design choices of GNNs.